CMS Postpones Final Pricing Decision on Genomic Sequencing Procedure Codes

The US Centers for Medicare and Medicaid Services last month said that it has postponed its final pricing decision for a set of six new CPT codes covering genomic sequencing procedures.
Earlier this year, the agency released preliminary pricing figures for the code set that raised concerns among stakeholders due to fears the low reimbursement would prohibit laboratories from performing tests. Late last month, CMS released its final pricing determinations for a variety of new codes, including the six genomic sequencing procedure codes, and eased some of those concerns.

Source: https://www.genomeweb.com/reimbursement-news/cms-postpones-final-pricing-decision-genomic-sequencing-procedure-codes